An official website of the United States government
Home
Name
Abiraterone acetate
Alternate Names
CB 7630
CB-7630
CB7630
Zytiga
Yonsa
Abbreviations
AA
Category
Hormones and hormonal mechanisms
Subcategory
Antiandrogenic
NSC Number
None
Primary Site
Prostate
Histology
None
Remarks
April 28, 2011: Zytiga received FDA approval for use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.
Coding
This drug should be coded
